Cargando…

The International Guideline Evaluation Screening Tool (IGEST): development and validation

BACKGROUND: Guideline adaptation provides an important alternative to de novo guideline development by making the process more efficient and reducing unnecessary duplication. The quality evaluation of international guidelines is an essential part of the adaptation process. The study aims at describi...

Descripción completa

Detalles Bibliográficos
Autores principales: D’angelo, Daniela, Coclite, Daniela, Napoletano, Antonello, Gianola, Silvia, Castellini, Greta, Latina, Roberto, Iacorossi, Laura, Fauci, Alice Josephine, Iannone, Primiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088113/
https://www.ncbi.nlm.nih.gov/pubmed/35538433
http://dx.doi.org/10.1186/s12874-022-01618-5
_version_ 1784704299686690816
author D’angelo, Daniela
Coclite, Daniela
Napoletano, Antonello
Gianola, Silvia
Castellini, Greta
Latina, Roberto
Iacorossi, Laura
Fauci, Alice Josephine
Iannone, Primiano
author_facet D’angelo, Daniela
Coclite, Daniela
Napoletano, Antonello
Gianola, Silvia
Castellini, Greta
Latina, Roberto
Iacorossi, Laura
Fauci, Alice Josephine
Iannone, Primiano
author_sort D’angelo, Daniela
collection PubMed
description BACKGROUND: Guideline adaptation provides an important alternative to de novo guideline development by making the process more efficient and reducing unnecessary duplication. The quality evaluation of international guidelines is an essential part of the adaptation process. The study aims at describing the development and validation of a new tool to screen trustworthy Clinical Practice Guidelines (CPGs) for their adoption/adaption: the International Guideline Evaluation Screening Tool (IGEST). METHODS: The process of developing the IGEST involved two main phases: 1) tool development and 2) content validation. The tool development phase comprised three stages, where the scope of the IGEST was defined and the item pool was generated and refined. The content validation was performed through the computation of a content validity index (CVI) based on the opinions of an expert panel. RESULTS: All the items obtained a CVI >0.78, which resulted in the validation of the instrument. The final instrument comprised four preliminary conditions and 12 criteria organised into three dimensions: (i) the management of conflict of interest; (ii) the quality of evidence and the coherence between evidence and recommendations; and (iii) the panel composition. CONCLUSION: The IGEST showed good content validity for assessing the quality of international guidelines. Using the new tool to select trustworthy guidelines might increase the likelihood that international clinical practice guidelines will be adopted/adapted to the local context by allowing a quick screening of existing guidelines trustworthiness and providing an acceptability threshold that supports the decision-making process. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-022-01618-5.
format Online
Article
Text
id pubmed-9088113
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90881132022-05-11 The International Guideline Evaluation Screening Tool (IGEST): development and validation D’angelo, Daniela Coclite, Daniela Napoletano, Antonello Gianola, Silvia Castellini, Greta Latina, Roberto Iacorossi, Laura Fauci, Alice Josephine Iannone, Primiano BMC Med Res Methodol Research BACKGROUND: Guideline adaptation provides an important alternative to de novo guideline development by making the process more efficient and reducing unnecessary duplication. The quality evaluation of international guidelines is an essential part of the adaptation process. The study aims at describing the development and validation of a new tool to screen trustworthy Clinical Practice Guidelines (CPGs) for their adoption/adaption: the International Guideline Evaluation Screening Tool (IGEST). METHODS: The process of developing the IGEST involved two main phases: 1) tool development and 2) content validation. The tool development phase comprised three stages, where the scope of the IGEST was defined and the item pool was generated and refined. The content validation was performed through the computation of a content validity index (CVI) based on the opinions of an expert panel. RESULTS: All the items obtained a CVI >0.78, which resulted in the validation of the instrument. The final instrument comprised four preliminary conditions and 12 criteria organised into three dimensions: (i) the management of conflict of interest; (ii) the quality of evidence and the coherence between evidence and recommendations; and (iii) the panel composition. CONCLUSION: The IGEST showed good content validity for assessing the quality of international guidelines. Using the new tool to select trustworthy guidelines might increase the likelihood that international clinical practice guidelines will be adopted/adapted to the local context by allowing a quick screening of existing guidelines trustworthiness and providing an acceptability threshold that supports the decision-making process. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-022-01618-5. BioMed Central 2022-05-10 /pmc/articles/PMC9088113/ /pubmed/35538433 http://dx.doi.org/10.1186/s12874-022-01618-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
D’angelo, Daniela
Coclite, Daniela
Napoletano, Antonello
Gianola, Silvia
Castellini, Greta
Latina, Roberto
Iacorossi, Laura
Fauci, Alice Josephine
Iannone, Primiano
The International Guideline Evaluation Screening Tool (IGEST): development and validation
title The International Guideline Evaluation Screening Tool (IGEST): development and validation
title_full The International Guideline Evaluation Screening Tool (IGEST): development and validation
title_fullStr The International Guideline Evaluation Screening Tool (IGEST): development and validation
title_full_unstemmed The International Guideline Evaluation Screening Tool (IGEST): development and validation
title_short The International Guideline Evaluation Screening Tool (IGEST): development and validation
title_sort international guideline evaluation screening tool (igest): development and validation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088113/
https://www.ncbi.nlm.nih.gov/pubmed/35538433
http://dx.doi.org/10.1186/s12874-022-01618-5
work_keys_str_mv AT dangelodaniela theinternationalguidelineevaluationscreeningtooligestdevelopmentandvalidation
AT coclitedaniela theinternationalguidelineevaluationscreeningtooligestdevelopmentandvalidation
AT napoletanoantonello theinternationalguidelineevaluationscreeningtooligestdevelopmentandvalidation
AT gianolasilvia theinternationalguidelineevaluationscreeningtooligestdevelopmentandvalidation
AT castellinigreta theinternationalguidelineevaluationscreeningtooligestdevelopmentandvalidation
AT latinaroberto theinternationalguidelineevaluationscreeningtooligestdevelopmentandvalidation
AT iacorossilaura theinternationalguidelineevaluationscreeningtooligestdevelopmentandvalidation
AT faucialicejosephine theinternationalguidelineevaluationscreeningtooligestdevelopmentandvalidation
AT iannoneprimiano theinternationalguidelineevaluationscreeningtooligestdevelopmentandvalidation
AT dangelodaniela internationalguidelineevaluationscreeningtooligestdevelopmentandvalidation
AT coclitedaniela internationalguidelineevaluationscreeningtooligestdevelopmentandvalidation
AT napoletanoantonello internationalguidelineevaluationscreeningtooligestdevelopmentandvalidation
AT gianolasilvia internationalguidelineevaluationscreeningtooligestdevelopmentandvalidation
AT castellinigreta internationalguidelineevaluationscreeningtooligestdevelopmentandvalidation
AT latinaroberto internationalguidelineevaluationscreeningtooligestdevelopmentandvalidation
AT iacorossilaura internationalguidelineevaluationscreeningtooligestdevelopmentandvalidation
AT faucialicejosephine internationalguidelineevaluationscreeningtooligestdevelopmentandvalidation
AT iannoneprimiano internationalguidelineevaluationscreeningtooligestdevelopmentandvalidation